Setback to Johnson and Johnson: Maha FDA cancels baby powder manufacturing license Ruchika Sharma17 Sept 2022 11:50 AM ISTFDA issued a show-cause notice to Johnson and Johnson under the Drugs Cosmetics Act 1940 and Rules, besides issuing instructions to the company to...
USFDA issues 2 observations for Alkem Labs St Louis facility Ruchika Sharma17 Sept 2022 10:30 AM ISTMaharashtra: Alkem Labs has recently announced that the US Food and Drug Administration (USFDA) has issued two observations after a pre-approval...
Novartis under Swiss competition commission radar over unlawful use of patent Ruchika Sharma16 Sept 2022 7:30 PM ISTNovartis said COMCO had started an investigation in collaboration with the European Commission into the assertion of a patent in the broader field of...
Denial of information on WHO suspension on Bharat Biotech Covaxin procurement: CIC issues show cause notice to CDSCO Ruchika Sharma16 Sept 2022 6:30 PM ISTIn response, CDSCO CPIO Sarkar gave a one line response, "No such information is available."
Zydus Lifesciences US arm secures USFDA nod for Sugammadex Injection Ruchika Sharma16 Sept 2022 1:30 PM ISTThe drug will be manufactured at the group’s injectables manufacturing facility at Jarod, India.
Neuberg Diagnostics unveils advanced Oncopathology reference laboratory in Mumbai Ruchika Sharma16 Sept 2022 12:30 PM ISTNew Delhi: Neuberg Diagnostics has launched Neuberg Oncopathology Reference Laboratory, a state-of-the-art second opinion Oncopathology...
IPA Secretary General says Indian pharma industry likely to grow to USD 130 billion by 2030 Ruchika Sharma16 Sept 2022 11:15 AM ISTDr Viranchi Shah opined that PLIs and cluster manufacturing will reduce India's dependence on imports.
Serum Institute of India to produce vaccines with Nigeria Ruchika Sharma15 Sept 2022 4:00 PM ISTNigeria: Nigeria will partner with Serum Institute of India to start local manufacturing of vaccines used in the country's immunisation programmes,...
Lancet report on unapproved antibiotic use in India is 'misleading, inappropriate': Govt official Ruchika Sharma15 Sept 2022 2:41 PM IST"Even though the authors have used the term 'unapproved' for formulations not approved by CDSCO, it is pertinent to note that these formulations were...
Moderna bivalent COVID booster vaccine gets interim nod in Singapore Ruchika Sharma15 Sept 2022 1:15 PM ISTSingapore: Singapore on Wednesday granted interim authorisation for a bivalent COVID-19 booster vaccine made by Moderna, the government said in a...
AstraZeneca unveils iPHARMACY to up-skill pharmacists across India Ruchika Sharma15 Sept 2022 12:00 PM ISTThe program will focus on inventory management, good pharmacy practices, customization of pharmacy for patient of future, and management of pharmacy...
Pfizer begins Phase 3 clinical trial of mRNA-based Influenza vaccine Ruchika Sharma15 Sept 2022 11:00 AM ISTNew York: Pfizer Inc. has announced that the first participants have been dosed in a pivotal Phase 3 clinical trial to evaluate the...
